lipophilicity

Salcaprozate sodium (SNAC), an oral absorption promoter, enhances passive transcellular permeation through small intestinal epithelia, making it a potent delivery agent for oral heparin and insulin by increasing lipophilicity via non-covalent macromolecule complexation.

NITD-916, a 4-hydroxy-2-pyridone derivative, is a mycobacterial enoyl reductase InhA inhibitor (IC50=570 nM) with oral activity and high lipophilicity. Capable of forming a ternary complex with InhA and NADH, blocking fatty acyl substrate binding and inhibiting mycolic acid synthesis, thereby exerting potent anti-tuberculosis effects.

Z-Glycine (Carbobenzoxyglycine) is a drug-lipid conjugates designed to promote brain penetration based on its lipophilicity and resemblance to lipids in biological membranes[1].

Isostearyl alcohol is a long-chain alcohol compound with excellent lubricity and lipophilicity, and is used in biochemical experiments and drug synthesis research.

2-Diethylamino-3'-benzyloxyacetanilide is an organic compound classified as an acetanilide derivative. 2-Diethylamino-3'-benzyloxyacetanilide may exhibit biological activity and is often used in organic synthesis, pharmaceutical chemistry, or biomedical research. Its lipophilicity and basicity may influence its solubility, metabolic properties, and pharmacological effects, making it potentially useful in the development of local anesthetics or related drugs.

(Iso)-TRPV4 antagonist 5 are potent, selective, and orally active transient receptor potential vanilloid 4 (TRPV4) channel blockers for the treatment of pulmonary edema and respiratory diseases. This compound was discovered through optimization of a spirocarbamate lead designed to reduce interstitial lung fluid. Research on its derivatives and related compounds primarily focuses on improving metabolic stability, reducing lipophilicity to enhance clearance, and increasing potency.

Me4Phen (compound 3) is an oxorhenium (V) complex that disrupts mitochondrial membrane potential and increases intracellular reactive oxygen species (ROS), leading to endoplasmic reticulum stress-mediated cancer cell necrosis (necrosis). With high lipophilicity, Me4Phen effectively overcomes Cisplatin resistance in various cancer cells.

Octisalate-D4 is the deuterated form of Octisalate. Octisalate (T0027) (Octyl salicylate) is an organic compound with high lipophilicity employed in sunscreens and cosmetics for absorbing UVB radiation.

AZM198 is a selective, orally active, and irreversible inhibitor of MPO with an IC50 of 15.0 nM. It exhibits an IC50 of 19 μM against CYP3A4 and possesses favorable lipophilicity, membrane permeability, metabolic stability, safety, and pharmacokinetic properties. AZM198 shows efficacy in improving vascular function, atherosclerotic plaques, pulmonary hypertension, nephropathy, visceral inflammatory fat deposition, ectopic fat deposition, and liver fibrosis.

Dichloro(bipyridine)platinum is a potent platinum-based antitumor complex and a structural analogue of cisplatin. The incorporation of the bipyridine ligand enhances its lipophilicity and planar stacking ability. The compound interacts with DNA through covalent binding or intercalation, forming cis-Pt-DNA adducts that disrupt DNA replication and transcription. Research indicates that such complexes effectively activate pro-apoptotic signaling pathways and exhibit significant growth inhibition across various cancer cell lines, including those resistant to cisplatin. It serves as a foundational scaffold for developing next-generation metallodrugs in oncology.

SARS-CoV-2 nsp14-IN-6 (Compound 35) ammonium is an inhibitor of the SARS-CoV-2 Nsp14 MTase, exhibiting an IC50 of 0.24 μM. This compound demonstrates significant antiviral activity by inhibiting the replication of SARS-CoV-2. Additionally, SARS-CoV-2 nsp14-IN-6 ammonium has enhanced lipophilicity, which improves cellular permeability, making it a valuable tool for human coronavirus research.

NBI-30545 is a potent corticotropin-releasing factor-1 antagonist with sufficient lipophilicity and water solubility for the treatment of stress disorders.

Cytosolic phospholipase A2α (cPLA2α) specifically catalyzes the hydrolysis of arachidonic acid from thesn-2-ester position of membrane phospholipids, playing a central role in initiating the synthesis of prostaglandins and leukotrienes, both important mediators of the inflammatory process.1CAY10641 is an inactive alcohol derivative of a highly potent (IC50= 12 nM) cPLA2α inhibitor.2The parent compound demonstrates strong anti-inflammatory effects when applied topically at a dose of 0.1 mg/ear in a mouse model of acute irritant contact dermatitis.2CAY10641 is rapidly cleared from the blood stream (only 0.5 μg/ml remains 30 minutes after 10 mg/kg intravenous administration to mice).2However, no other biological effects have been reported. 1.Schaloske, R.H., and Dennis, E.A.The phospholipase A2 superfamily and its group numbering systemBiochemica et Biophysica Acta17611246-1259(2006) 2.Drews, A., Bovens, S., Roebrock, K., et al.1-(5-carboxyindol-1-yl)propan-2-one inhibitors of human cytosolic phospholipase A2α with reduced lipophilicity: Synthesis, biological activity, metabolic stability, solubility, bioavailability, and topical in vivo activityJournal of Medicinal Chemistry535165-5178(2010)

BuChE-IN-4 is a potent inhibitor of BuChE (IC50: 7.7 nM) and exhibits mild antioxidant capacity, non-toxicity, lipophilicity and neuroprotective effects.

Toliprolol is a non-selective beta-adrenergic receptor antagonist with moderate lipophilicity that affects heart rate, myocardial contractility, and cardiovascular load. Toliprolol has been used in studies of hypertension and cardiovascular pharmacology and is commonly employed as a tool compound for investigating beta-receptor-mediated signal transduction.

AZD6642 is a potential and selective 5-Lipoxygenase activating Protein (FLAP) inhibitor. AZD6642 shows high specific potency and low lipophilicity resulting in a selective and metabolically stable profile. Based on initial PK/PD relations a low dose to human was predicted.

Trandolaprilate hydrate, the main bioactive metabolite of Trandolapril and a potent angiotensin-converting enzyme (ACE) inhibitor, exhibits high lipophilicity and partially inhibits angiotensin-I-mediated c-fos induction.

omega-3 Arachidonic acid ethyl ester is a polyunsaturated fatty acid suitable for biochemical experiments and drug synthesis research.

Anticancer agent 162 (compound 1d) is a potent theranostic agent that selectively induces oncosis in Hela cells, exhibiting pronounced lipophilicity and cytotoxicity [1].

AMCPy, a potent electron paramagnetic resonance (EPR) brain imaging agent, boasts excellent lipophilicity, facilitating its penetration through the blood-brain barrier (BBB) [1].

AZ760 is a CCR8 antagonist that demonstrates excellent potency, good lipophilicity, and a high free fraction in blood, but exhibits unacceptable hERG inhibition [1].

Sodium ionophore VI is a highly selective sodium ionophore extensively utilized in the development of cation optical sensors. This compound features high lipophilicity, allowing it to function as a neutral carrier embedded within polymer membranes (e.g., PVC membranes) in combination with lipophilic anionic dyes like fluorescein derivatives. By mediating the selective exchange of sodium ions at the membrane interface, Sodium ionophore VI facilitates the conversion of ion concentration changes into optical signals, enabling the monitoring of sodium, potassium, and ammonium ions in complex biological or environmental samples.

Sp-8-Br-PET-cGMPS is a membrane-permeable PKG activator and an inhibitor of the membrane-permeable retinal cGMP-gated ion channels (cGMP-gated ion channel). It also serves as an activator for cGMP-dependent protein kinase I α and β. Resistant to mammalian cyclic nucleotide-dependent phosphodiesterases, Sp-8-Br-PET-cGMPS does not undergo metabolic side effects and exhibits stronger lipophilicity and permeability compared to Sp-8-pCPT-cGMPS. This compound is useful for investigating the role of the cGMP signaling pathway in the nervous system.

Potassium ionophore III (BME-44) is a highly specific potassium ion carrier based on a bis-crown ether structure. Featuring high lipophilicity, it effectively facilitates potassium transport across lipid bilayers and exhibits excellent selectivity over sodium (Na+) and ammonium (NH4+) ions. BME-44 is commonly utilized in the development of ion-selective electrodes (ISEs) and chemical sensors, where it is covalently immobilized or incorporated into polymer membranes for precise monitoring of potassium ions in environmental or biological samples.